Carregant...
Camelid Single-Domain Antibodies: Promises and Challenges as Lifesaving Treatments
Since the discovery of camelid heavy-chain antibodies in 1993, there has been tremendous excitement for these antibody domains (VHHs/sdAbs/nanobodies) as research tools, diagnostics, and therapeutics. Commercially, several patents were granted to pioneering research groups in Belgium and the Netherl...
Guardat en:
| Autor principal: | |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
MDPI AG
2022-04-01
|
| Col·lecció: | International Journal of Molecular Sciences |
| Matèries: | |
| Accés en línia: | https://www.mdpi.com/1422-0067/23/9/5009 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|